Abstract:Background & Aims: Prolactin (PRL) is a multifunctional polypeptide with effects on metabolism, however, little is known about its effect on hepatic steatosis and lipid metabolism. Herein, we aimed to assess the role of PRL in the development of non-alcoholic fatty liver disease (NAFLD). Methods: The serum PRL levels of 456 patients with NAFLD, 403 controls without NAFLD diagnosed by ultrasound, and 85 individuals with liver histology obtained during metabolic surgery (44 female and 30 male patients with NAFLD and 11 age-matched non-NAFLD female individuals) were evaluated. The expression of the gene encoding the prolactin receptor (PRLR) and signalling molecules involved in hepatic lipid metabolism were evaluated in human liver and HepG2 cells. The effects of overexpression of PRLR or fatty acid translocase (FAT)ICD36 or knockdown of PRLR on hepatic lipid metabolism were tested in free fatty acid (FFA)-treated HepG2 cells. Results: Circulating PRL levels were lower in individuals with ultrasound-diagnosed NAFLD (men: 7.9 [range, 5.9-10.3] mu g/L; women: 8.7 [range, 6.1-12.4]mu g/L) than those with non-NAFLD (men: 9.1 [range, 6.8-13.0] mu g/L, p = 0.002; women: 11.6 [range, 8.2-16.1] mu g/L, p <0.001). PRL levels in patients with biopsy-proven severe hepatic steatosis were lower compared with those with mild-to-moderate hepatic steatosis in both men (8.3 [range, 5.4-9.5] mu g/L vs. 9.7 [range, 7.1-12.3] mu g/L p = 0.031) and women (8.5 [range, 4.2-10.6] mu g/L vs. 9.8 [range, 8.2-15.7] mu g/L, p = 0.027). Furthermore, hepatic PRLR gene expression was significantly reduced in patients with NAFLD and negatively correlated with CD36 gene expression. In FFA-induced HepG2 cells, PRL treatment or PRLR overexpression significantly reduced the expression of CD36 and lipid content, effects that were abrogated after silencing of PRLR. Furthermore, overexpression of CD36 significantly reduced the PRL-mediated improvement in lipid content. Conclusions: Our results reveal a novel association between the central nervous system and the liver, whereby PRL/PRLR improved hepatic lipid accumulation via the CD36 pathway. Lay summary: Our clinical study suggests a negative association between prolactin (PRL)/prolactin receptor (PRLR) and the presence of non-alcoholic fatty liver disease (NAFLD). Using cell experiments, we found that PRL ameliorates hepatic steatosis via the hepatic PRLR and fatty acid translocase (FAT)/CD36, a key transporter of free fatty acid uptake in liver. Our findings suggest a novel approach to improving NAFLD using PRL and PRLR. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

The increase in prolactin was an adaptive response for protecting against metabolic disorders in obesity

Serum prolactin levels were positively related to metabolic indexes and disorders in male obese patients

Association between prolactin and non-alcoholic fatty liver disease in overweight and obese patients

Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans

(352) The Metabolic Role Of Prolactin: A Systematic Review And Meta-Analysis

Prolactin Improves Hepatic Steatosis Via CD36 Pathway.

Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome

Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center

PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway

Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis

Severe obesity caused by prolactinoma related to the abnormal insulin metabolism—A case report

BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort

Regulatory T cells: IDO — influencing dendritic-cell options

The relationship between low prolactin and type 2 diabetes

Severe Hyperprolactinemia Promotes Brown Adipose Tissue Whitening and Aggravates High Fat Diet Induced Metabolic Imbalance

Lower Serum PRL is Associated with the Development of Non-Alcoholic Fatty Liver Disease: a Retrospective Cohort Study

Effect of Age, Gender, Food Intake, Obesity, and Smoking on Serum Levels of Prolactin in Healthy Adults

A Century of Prolactin: Emerging Perspectives as a Metabolic Regulator

Prolactin in men's health and disease

Association between serum prolactin levels and insulin resistance in non-diabetic men

Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study